... BioSpace - Gentris Corporation News, Search Jobs, Events Quote: Pharmacogenetics is the study of the genetic basis of drug response.1 Pharmacogenomics is a term which is often used interchangeably, but refers to pharmacogenetics plus genomics and proteomics.2 The recognition that most human drug responses are multifactorial has led ...

... over the coming months be attending several conferences in the UK, Europe and the US to highlight its pharmacogenetics expertise. Given the genetic resources of its founding partners, London Genetics has broad ... parties are working on genetic markers for drug-induced cardiac arrhythmia. About pharmacogenetics Genetic differences between individuals means that drug response rates are often variable ...

... , including human genetics and genomics, oncology, neuroscience, gene therapy, molecular medicine, pharmacology, and biomedical sciences. Updates with regard to diagnostic testing, pharmacogenetics, predicting disease susceptibility, and other important research components as well as chapters dedicated to cardiovascular disease, oncology, inflammatory disease, metabolic disease, neuropsychiatric ...

... . Writing for every interested citizen and consumer, the Schoemakers illuminate the hottest technologies and most controversial issues associated with contemporary biotechnology--including stem cells, cloning, pharmacogenetics, DNA chips, proteomics, gene therapy, and much more. Then, drawing on Paul Schoemaker's unsurpassed experience helping global organizations prepare for the future, the ...

... management experience -- solid biology background including experience with oncology vocabularies/ontologies -- experience with genomic data analysis (gene expression, genotyping, sequencing), biomarkers, and pharmacogenetics applied to clinical samples -- 5+ yrs of scientific programming experience -- comfortable working with physicians and IT groups -- familiar with drug discovery and ...

... have one called the Global Alliance in Pharmacogenomics Japan (GAP-J or PGRN-Riken), and that’s a consortium between the Center for Genomic Medicine in RIKEN at Yokohama, Japan, and the Pharmacogenetics Research Network (PGRN) funded by the National Institutes of Health (NIH). That consortium’s gotten together, and there are 14 genome-wide association studies that are ongoing. That&# ...